Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Discovery of (1R,2R)-N-(4-(6-isopropylpyridin-2-yl)-3-(2-methyl-2H-indazol-5-yl)isothiazol-5-yl)-2-methylcyclopropanecarboxamide, a potent and orally efficacious mGlu5 receptor negative allosteric modulator.
Hao J, Dehlinger V, Fivush AM, Rudyk HC, Britton TC, Hollinshead SP, Vokits BP, Clark BP, Henry SS, Massey SM, Peng L, Dressman BA, Heinz BA, Roberts EF, Bracey-Walker MR, Swanson S, Catlow JT, Love PL, Tepool AD, Peters SC, Simmons RM, Iyengar S, McKinzie DL, Monn JA. Hao J, et al. Among authors: dehlinger v. Bioorg Med Chem Lett. 2013 Mar 1;23(5):1249-52. doi: 10.1016/j.bmcl.2013.01.009. Epub 2013 Jan 12. Bioorg Med Chem Lett. 2013. PMID: 23374867
Synthesis and Preclinical Characterization of LY3154885, a Human Dopamine D1 Receptor Positive Allosteric Modulator with an Improved Nonclinical Drug-Drug Interaction Risk Profile.
Hao J, Beck J, Zhou X, Lackner GL, Johnston R, Reinhard M, Goldsmith P, Hollinshead S, Dehlinger V, Filla SA, Wang XS, Richardson J, Posada M, Mohutsky M, Schober D, Katner JS, Chen Q, Hu B, Remick DM, Coates DA, Mathes BM, Hawk MK, Svensson KA, Hembre E. Hao J, et al. Among authors: dehlinger v. J Med Chem. 2022 Mar 10;65(5):3786-3797. doi: 10.1021/acs.jmedchem.1c01887. Epub 2022 Feb 17. J Med Chem. 2022. PMID: 35175768
Chikungunya virus infection in patients on biotherapies.
Brunier L, Polomat K, Deligny C, Dehlinger V, Numéric P, JeanBaptiste G, Arfi S, de Bandt M. Brunier L, et al. Among authors: dehlinger v. Joint Bone Spine. 2016 Mar;83(2):245-6. doi: 10.1016/j.jbspin.2015.08.004. Epub 2015 Oct 24. Joint Bone Spine. 2016. PMID: 26603267 No abstract available.
Dengue fever in patients under biologics.
Deligny C, de Bandt M, Dehlinger V, Numéric P, Cabié A, Lombard F, Polomat K, JeanBaptiste G, Arfi S. Deligny C, et al. Among authors: dehlinger v. J Clin Virol. 2014 Nov;61(3):442-3. doi: 10.1016/j.jcv.2014.08.011. Epub 2014 Aug 26. J Clin Virol. 2014. PMID: 25200649
Rituximab for patients with myopathy associated with anti-signal recognition particle antibodies: comment on the article by Valiyil et al.
Deligny C, Goëb V, Dueymes M, Kahn V, Dehlinger V, Baptiste GJ, Amarof K, Arfi S. Deligny C, et al. Among authors: dehlinger v. Arthritis Care Res (Hoboken). 2011 Mar;63(3):460; author reply 461. doi: 10.1002/acr.20378. Epub 2010 Oct 27. Arthritis Care Res (Hoboken). 2011. PMID: 20981806 Free article. No abstract available.
[Diabetic muscular necrosis: three Afrocaribbean cases].
Baubion E, Deligny C, Numéric P, Dehlinger V, Jean-Baptiste G, Arfi S. Baubion E, et al. Among authors: dehlinger v. Rev Med Interne. 2009 Feb;30(2):161-4. doi: 10.1016/j.revmed.2008.08.021. Epub 2008 Oct 22. Rev Med Interne. 2009. PMID: 18947907 French.
[Periocular lesions].
Deligny C, Bechac M, Dehlinger V, Arfi S, Jean-Baptiste G, Panelatti G. Deligny C, et al. Among authors: dehlinger v. Rev Med Interne. 2008 Apr;29(4):323-4. doi: 10.1016/j.revmed.2007.11.003. Epub 2008 Jan 8. Rev Med Interne. 2008. PMID: 18191878 French. No abstract available.
11 results